Table 1.
Baseline characteristics of patients in training and validation datasets
| Training (n = 218) | Validation 1 (n = 96) | Validation 2 (n = 69) | p | |
|---|---|---|---|---|
| Age (years) | 60.91 ± 11.94 | 62.38 ± 12.71 | 61.33 ± 13.07 | 0.627 |
| Gender | 0.570 | |||
| Female | 110 (50.46%) | 43 (44.79%) | 36 (52.17%) | |
| Male | 108 (49.54%) | 53 (55.21%) | 33 (47.83%) | |
| Diameter (mm) | 55.01 ± 40.64 | 54.96 ± 41.08 | 61.80 ± 42.43 | 0.461 |
| Ki-67 PI | 0.307 | |||
| Ki-67 ≤ 10% | 191 (87.61%) | 87 (90.62%) | 57 (82.61%) | |
| Ki-67 > 10% | 27 (12.39%) | 9 (9.38%) | 12 (17.39%) | |
| CER (%) | 2.26 ± 0.81 | 2.27 ± 0.77 | 2.24 ± 0.76 | 0.971 |
CER, contrast enhancement ratio; PI, proliferation index